Tobacco control environment: Cross-sectional survey of policy implementation, social unacceptability, knowledge of tobacco health harms and relationship to quit ratio in 17 low-income, middle-income and high-income countries
Objectives: This study examines in a cross-sectional study 'the tobacco control environment' including tobacco policy implementation and its association with quit ratio. Setting: 545 communities from 17 high-income, upper-middle, low-middle and low-income countries (HIC, UMIC, LMIC, LIC) i...
Similar Items
-
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
by: Chow C.K.; Nguyen T.N.; Marschner S.; Diaz R.; Rahman O.; Avezum A.; Lear S.A.; Teo K.; Yeates K.E.; Lanas F.; Li W.; Hu B.; Lopez-Jaramillo P.; Gupta R.; Kumar R.; Mony P.K.; Bahonar A.; Yusoff K.; Khatib R.; Kazmi K.; Dans A.L.; Zatonska K.; Alhabib K.F.; Kruger I.M.; Rosengren A.; Gulec S.; Yusufali A.; Chifamba J.; Rangarajan S.; McKee M.; Yusuf S.
Published: (2020) -
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
by: Chow C.K.; Ramasundarahettige C.; Hu W.; AlHabib K.F.; Avezum A., et al.
Published: (2018) -
Cardiovascular risk and events in 17 low-, middle-, and high-income countries
by: Yusuf S.; Rangarajan S.; Teo K.; Islam S.; Li W.; Liu L.; Bo J.; Lou Q.; Lu F.; Liu T.; Yu L.; Zhang S.; Mony P.; Swaminathan S.; Mohan V.; Gupta R.; Kumar R.; Vijayakumar K.; Lear S.; Anand S.; Wielgosz A.; Diaz R.; Avezum A.; Lopez-Jaramillo P.; Lanas F.; Yusoff K.; Ismail N.; Iqbal R.; Rahman O.; Rosengren A.; Yusufali A.; Kelishadi R.; Kruger A.; Puoane T.; Szuba A.; Chifamba J.; Oguz A.; McQueen M.; McKee M.; Dagenais G.
Published: (2014) -
Balanced Approach Regulatory Measures for Excise Tax on Tobacco and Nicotine-Based Products with Differential Degrees of Harm
by: Hashim H.N.M.; Ibrahim Z.; Ghazali N.; Yunus N.; Othman R.D.
Published: (2024) -
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data
by: Khatib R.; McKee M.; Shannon H.; Chow C.; Rangarajan S.; Teo K.; Wei L.; Mony P.; Mohan V.; Gupta R.; Kumar R.; Vijayakumar K.; Lear S.A.; Diaz R.; Avezum A.; Lopez-Jaramillo P.; Lanas F.; Yusoff K.; Ismail N.; Kazmi K.; Rahman O.; Rosengren A.; Monsef N.; Kelishadi R.; Kruger A.; Puoane T.; Szuba A.; Chifamba J.; Temizhan A.; Dagenais G.; Gafni A.; Yusuf S.
Published: (2016)